Abbott Laboratories's Sturgis, Michigan, plant will soon be producing baby formula again, raising hopes the end of the nation's formula shortage may be in sight.
Abbott began a formula recall in February because of reports of bacterial infections discovered in babies who had consumed its product.
Food and Drug Administration officials inspected Abbott's Sturgis plant, finding "shocking" results: cracks in vital equipment, a lack of appropriate hand-washing by employees and evidence of previous contamination.
Before the winter recall, Abbott had controlled an estimated 40% of the infant formula market, including Similac.
Abbott said in a news release it will start production of EleCare with initial product release anticipated June 20.
Data released by Datasembly showed 73% of baby products were out of stock nationally as of May 22.
Do you want more business news? Check out B Magazine, and the B Magazine email newsletter. Go to www.semissourian.com/newsletters to find out more.
Connect with the Southeast Missourian Newsroom:
For corrections to this story or other insights for the editor, click here. To submit a letter to the editor, click here. To learn about the Southeast Missourian’s AI Policy, click here.